Stella Pharma Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	2,823	3,206	2,052	2,710	3,276
Short-Term Investments	-	-	300	-	-
Cash & Short-Term Investments	2,823	3,206	2,352	2,710	3,276
Cash Growth	-11.95%	36.31%	-13.21%	-17.28%	161.87%
Accounts Receivable	67	714	76	59	16
Receivables	67	714	76	59	16
Inventory	1,295	1,230	1,116	940	773
Prepaid Expenses	66	49	40	39	36
Other Current Assets	102	44	45	44	74
Total Current Assets	4,353	5,243	3,629	3,792	4,175
Property, Plant & Equipment	47	66	81	102	92
Long-Term Investments	43	57	57	371	382
Other Intangible Assets	42	49	52	61	68
Other Long-Term Assets	1	2	1	3	1
Total Assets	4,486	5,417	3,820	4,329	4,718
Accounts Payable	-	22	75	49	48
Accrued Expenses	8	7	4	6	2
Current Portion of Long-Term Debt	158	158	160	160	160
Current Income Taxes Payable	83	197	212	202	92
Other Current Liabilities	10	6	4	4	6
Total Current Liabilities	259	390	455	421	308
Long-Term Debt	588	608	773	933	1,093
Pension & Post-Retirement Benefits	59	59	53	47	51
Other Long-Term Liabilities	1,154	1,153	163	176	187
Total Liabilities	2,060	2,210	1,444	1,577	1,639
Common Stock	2,859	2,859	2,938	3,300	3,808
Additional Paid-In Capital	348	489	195	220	1,908
Retained Earnings	-780	-140	-763	-778	-2,636
Comprehensive Income & Other	-1	-1	6	10	-1
Shareholders' Equity	2,426	3,207	2,376	2,752	3,079
Total Liabilities & Equity	4,486	5,417	3,820	4,329	4,718
Total Debt	746	766	933	1,093	1,253
Net Cash (Debt)	2,077	2,440	1,419	1,617	2,023
Net Cash Growth	-14.88%	71.95%	-12.25%	-20.07%	-
Net Cash Per Share	61.05	73.10	45.81	56.00	72.04
Filing Date Shares Outstanding	34.02	34.02	31.22	29.48	28.65
Total Common Shares Outstanding	34.02	34.02	31.22	29.48	28.65
Working Capital	4,094	4,853	3,174	3,371	3,867
Book Value Per Share	71.31	94.27	76.10	93.35	107.48
Tangible Book Value	2,384	3,158	2,324	2,691	3,011
Tangible Book Value Per Share	70.07	92.83	74.43	91.28	105.10